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anno Ulmer, PHD,† Otmar Pachinger, MD, FACC,* Franz Weidinger, MD, FACC*
nnsbruck, Austria
OBJECTIVES We sought to examine the prognostic value of brachial artery (BA) flow-mediated vasodila-
tion (FMD) and intima-media thickness (IMT) in patients admitted for invasive evaluation
of chest pain.
BACKGROUND Both FMD and IMT of the BA have been associated with coronary risk factors and the
presence of coronary artery disease (CAD). Recent studies on the prognostic value of FMD
have been conflicting.
METHODS In 398 consecutive patients (age 54  9 years) undergoing coronary angiography, FMD and
IMT of the BA were measured using high-resolution ultrasound (13 MHz). Patients were
divided into two groups according to the FMD median (7.6%). After a mean follow-up of 39
 12 months, cardiovascular events were documented.
RESULTS No difference was found in the number of cardiovascular events between groups. On
multivariate Cox regression analysis, including age, number of risk factors, BA diameter,
presence of CAD, FMD, and IMT, only the presence of CAD and IMT remained
significantly associated with cardiovascular events.
CONCLUSIONS Intima-media thickness predicted late (up to 4 years) cardiovascular events in a large
population admitted for evaluation of chest pain. In contrast, the long-term prognostic value
of a single baseline measure of BA-FMD seems to be limited. (J Am Coll Cardiol 2005;46:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.05.0701006–10) © 2005 by the American College of Cardiology Foundation
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pndothelial dysfunction is an early phenomenon in athero-
clerosis and often precedes structural changes and clinical
anifestations (1). Flow-mediated vasodilation (FMD) is a
on-invasive test using high-resolution ultrasound for the
ssessment of endothelial function in the brachial artery
BA) (2). An improvement of BA-FMD after various
herapeutic interventions has been demonstrated (3,4), sug-
esting that FMD may serve as a surrogate marker for
ong-term clinical benefit. Accordingly, some (5–7) but not
ll (8) recent studies have shown an association of FMD
ith cardiovascular events. Thus, the prognostic value of
ndothelial function testing is not yet established.
Intima-media thickness (IMT) is another sonographic
arameter of atherosclerosis (9) and is usually measured in
he carotid and/or femoral arteries (10,11). The IMT
easurement of the BA is less well established, although
therosclerosis also occurs in this vessel (12). The sono-
raphic assessment of the BA has the advantage of obtain-
ng functional and morphologic information within the
ame artery.
The aim of this prospective study was to compare the
rognostic importance of BA-FMD and IMT in a large
roup of patients admitted for invasive evaluation of chest
ain.
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tudy population. A total of 398 male patients (mean age
4  9 years) in whom coronary angiography was per-
ormed due to chest pain, as well as a positive exercise stress
est, were consecutively enrolled. Exclusion criteria were age
70 years, acute coronary syndrome, congestive heart fail-
re, left ventricular ejection fraction 40%, and significant
alvular disease. Coronary artery disease (CAD) was defined
s 30% diameter stenosis in one or more major vessels.
ritten, informed consent was obtained from all patients.
tudy protocol. At entry, fasting blood samples were
btained and coronary risk factors were assessed as previ-
usly described (13,14). On the day after angiography,
igh-resolution ultrasound (13 MHz, Acuson Sequoia C
56, Mountain View, California) was used for the assess-
ent of FMD and IMT. After a mean follow-up of 39 
2 months, cardiovascular events were documented by
hone calls to the patients, followed by a review of hospital
ecords for verification. In the power analysis, we calculated
hat a sample size of 150 patients in each group would have
0% power to detect a 10% difference in events after 36
onths (alpha  0.05).
ltrasound studies of the BA. The ultrasound examina-
ion was performed between 9 AM and 12 AM by an observer
linded to the patients’ diagnoses, as previously described
3,13). After a resting period of at least 10 min in the supine
osition, the right BA was scanned. After recording of
esting diameters (electrocardiographically triggered to the
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September 20, 2005:1006–10 Prognostic Value of Endothelial Functioneak of the T wave), a cuff was placed on the upper arm and
nflated to suprasystolic levels for 5 min. For all 120 s after
eflation of the cuff, serial post-hyperemia scans were stored
n the hard disk. Finally, 0.8 mg nitroglycerin was given
ublingually, and diameters within 10 min were recorded
nitroglycerin-mediated vasodilation [NMD]). The maxi-
um diameter after cuff release and nitroglycerin applica-
ion were used for calculation of FMD and NMD.
Intima-media thickness was assessed as previously de-
cribed (13,14); the IMT at the far wall was measured
irectly as the distance between the lumen-intima and
edia-adventitia border by using a regional expansion
ystem in addition to 13-MHz ultrasound. Measurements
ere made at two sites per image in four different images per
atient. Interobserver variability of FMD and IMT mea-
urements in our laboratory has been previously published
3,13).
tatistical analysis. Data are expressed as the mean value
SD (ranges) or as frequencies (percentages). A normal
istribution of variables was tested using a Kolmogorov-
mirnov test with Lilliefors’ correction. Patient character-
stics between groups were compared using the Student t
est or Mann-Whitney U test for continuous variables and
hi-square test or Fisher exact test for categorical variables,
s appropriate. Cumulative event rates were calculated
ccording to the Kaplan-Meier method and log-rank test.
ox regression analyses were performed to determine the
Abbreviations and Acronyms
BA  brachial artery
CAD  coronary artery disease
FMD  flow-mediated vasodilation
IMT  intima-media thickness
NMD  nitroglycerin-mediated vasodilation
able 1. Characteristics of Patients
FMD <7.6%
(n  199)
ge (yrs) 55  9 (31–78)
revalent CAD 155 (78%)
umber of risk factors 2.0  1.0 (0–5)
ypertension 107 (54%)
mokers 69 (35%)
ypercholesterolemia 151 (76%)
iabetes mellitus 24 (12%)
ositive family history 49 (25%)
otal cholesterol (mg/dl) 218  54 (96–602)
DL cholesterol (mg/dl) 143  41 (31–330)
DL cholesterol (mg/dl) 46  14 (23–109)
riglycerides (mg/dl) 171  148 (50–1,580)
ody mass index (kg/m2) 27  4 (19–41)
A diameter (mm) 4.5  0.5 (3.1–6.0)
A-IMT (mm) 0.37  0.06 (0.21–0.53)
tatin 49 (25%)
CE inhibitor 52 (26%)
ata are presented as the mean value  SD or number (%) of subjects. Significant
ACE  angiotensin-converting enzyme; BA  brachial artery; CAD  coronary arter
MT  intima-media thickness; LDL  low-density lipoprotein.ariables independently associated with cardiovascular
vents. A p value 0.05 was considered statistically signif-
cant. All analyses were conducted with the use of statistical
oftware (SPSS for Windows, version 10.1, SPSS Inc.,
hicago, Illinois).
ESULTS
atient characteristics. The clinical characteristics are
ummarized in Table 1. Of the 315 CAD patients, 57% had
t least one significant coronary lesion (70% diameter
tenosis). Percutaneous coronary interventions were not
ignificantly different between groups. Based on the median
alue of FMD (7.6%), patients were divided into two
roups: patients below (group 1) and above the median
alue (group 2).
Flow-mediated vasodilation (8.2  4.2% vs. 7.9  3.8%,
 0.61) and NMD (17.6  7.3% vs. 17.8  6.3%, p 
.82) were not significantly different between CAD and
on-CAD patients, whereas IMT was greater in CAD
atients compared with non-CAD patients (0.37  0.07
m vs. 0.34  0.08 mm, p  0.01).
ollow-up. During a mean follow-up of 39  12 months
range 21 to 78 months), 44 adverse events were docu-
ented: cardiac death (n  4), myocardial infarction (n 
), percutaneous coronary intervention as well as bypass
urgery (at least six months after baseline evaluation) (n 
4), repeat coronary angiography with documented progres-
ion of coronary atherosclerosis (n  3), or hospitalization
or worsening angina and exclusion of instability (n  5).
he proportion of patients who stopped smoking, as well as
hanges in medication and body mass index, were not
ignificantly different between groups.
No significant difference in outcome was observed when
atients were divided according to the median FMD value
FMD >7.6%
(n  199) p Value
53  10 (27–74) 0.08
160 (80%) 0.62
1.9  0.9 (0–4) 0.44
109 (55%) 0.92
63 (32%) 0.59
154 (77%) 0.55
9 (5%) 0.01
41 (21%) 0.40
218  44 (104–367) 0.96
143  41 (32–279) 0.99
47  14 (20–123) 0.38
172  94 (41–736) 0.91
27  3 (19–40) 0.33
4.0  0.5 (2.9–5.4) <0.01
0.36  0.8 (0.16–0.53) 0.59
46 (23%) 0.73
37 (19%) 0.07
(p  0.05) are highlighted in bold.values
y disease; FMD  flow-mediated vasodilation; HDL  high-density lipoprotein;
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Prognostic Value of Endothelial Function September 20, 2005:1006–10r tertiles (Fig. 1). In a third analysis, groups were formed
ccording to absolute changes in BA diameter during
yperemia compared with baseline, which did not reveal any
ssociation with cardiovascular events (19 vs. 25 events, p
.47). Neither NMD (22 vs. 22 events, p  0.97) nor the
MD/NMD ratio (25 vs. 19 events, p  0.46) was
redictive of outcome.
When patients were classified according to their IMT,
atients above the median value of 0.37 mm had signifi-
antly more events compared with patients whose value was
0.37 mm (Fig. 2). In addition, patients were divided into
roups of IMT tertiles. Overall, we found a borderline
ignificant difference with regard to cardiovascular events
Fig. 2).
Finally, we calculated several Cox regression analyses
igure 1. Kaplan-Meier curves for flow-mediated vasodilation (FMD) m
og-rank test.igure 2. Kaplan-Meier curves for intima-media thickness (IMT) median (left
est.Tables 2 and 3). Only the presence of CAD and BA-IMT
emained significantly associated with cardiovascular events
Table 3).
ISCUSSION
n this prospective study of 398 patients undergoing coro-
ary angiography, BA-IMT but not FMD was predictive of
ong-term cardiovascular events.
The clinical usefulness of non-invasive tests largely de-
ends on their reproducibility and proof of predictive value.
he role of FMD in this regard is still debated. Neunteufl
t al. (15) followed 73 patients with chest pain for five years
nd showed that patients with FMD 10% had signifi-
antly less events than did patients below this threshold.
(left) and FMD tertiles (right). The p value was calculated using the) and IMT tertiles (right). The p value was calculated using the log-rank
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September 20, 2005:1006–10 Prognostic Value of Endothelial Functionfter correction for the presence of CAD, this association
o longer remained significant. In another study of 152
atients with CAD, only the FMD/NMD ratio but not
MD was independently predictive of cardiovascular events
fter a mean follow-up of 34 months (16). More recently,
athi et al. (8) reported data on 444 patients with a high
ardiovascular risk profile and demonstrated that carotid
MT but not FMD was related to cardiovascular events.
Our study is in accordance with the latter observation in
hat morphologic rather than functional arterial changes are
ssociated with outcome. Furthermore, it is the first study to
nclude both functional and morphologic information
ithin the same artery in a multivariate model for the
rediction of cardiovascular events. In contrast to our
bservation, other studies have shown an independent
ssociation of FMD with prognosis. Gokce et al. (5) showed
hat patients in the highest FMD tertile had a better
hort-term and long-term clinical outcome after vascular
urgery (7). Recently, Brevetti et al. (6) demonstrated that
A-FMD had an additive prognostic value to the ankle-
rachial pressure index in 131 patients with peripheral
rterial disease. Several factors may explain the discrepancy
etween our data and the latter three studies. First, there are
mportant differences among study populations. Second,
ngiographic documentation of CAD was not performed in
ll patients of previous studies. Third, disparate results on
he prognostic value of FMD also relate to the interindi-
idual variability and the lack of standardization, which still
recludes its recommendation as a screening test in clinical
ractice (17,18).
From our observation, long-term cardiovascular outcome
ay not be predicted by a single baseline FMD measure. We
annot exclude, however, that improvement in FMD, which
as been shown for a variety of therapeutic interventions,
as a prognostic impact. Indeed, Chan et al. (16) showed
Table 2. Cox Regression Analyses for Cardiov
Covariates HR (95% CI)
Age (per yr) 0.99 (0.96–1.03)
No. of risk factors 1.30 (0.94–1.79)
BA diameter 0.81 (0.43–1.53)
Presence of CAD 6.61 (1.57–27.8)
BA-FMD 7.6% 1.10 (0.57–2.11)
BA-NMD 17.9%
Significant values (p  0.05) are highlighted in bold.
CI  confidence interval; NMD  nitroglycerin-mediated
able 3. Cox Regression Analysis for Cardiovascular Events
ncluding FMD and IMT
Covariates HR (95% CI) p Value
ge (per yr) 0.98 (0.94–1.02) 0.29
o. of risk factors 1.22 (0.86–1.73) 0.28
A diameter 0.96 (0.48–1.90) 0.91
resence of CAD 9.18 (1.24–68.0) 0.03
A-FMD median 1.52 (0.75–3.08) 0.24
A-IMT median 2.20 (1.08–4.47) 0.03ignificant values (p  0.05) are highlighted in bold.
Abbreviations as in Tables 1 and 2.hat serial measurements of FMD may improve the prog-
ostic value of this test. Therefore, serial rather than single
easurements of BA-FMD may be more useful in the
ssessment of cardiovascular risk. Therapeutic improvement
n endothelial function, however, has not always translated
nto better clinical outcomes (18).
The finding that BA-IMT was predictive of cardiovas-
ular outcome is in line with studies using carotid or femoral
rtery IMT (10,11). Therefore, morphologic examination of
ifferent vascular beds, perhaps in combination with serial
ssessment of endothelial function, may improve the man-
gement of high-risk patients, a concept that deserves
urther investigation.
tudy limitations. We found no univariate or multivariate
orrelation between coronary risk factors and FMD. This
ay be due to the homogeneous risk profile of our popu-
ation, as two-thirds of the patients had one or two coronary
isk factors. In accordance with this interpretation, a recent
ublication in 1,154 male patients did not find a significant
ssociation between FMD and Framingham risk scores
19). All patients had coronary angiography, which may
ntroduce selection bias toward symptomatic patients.
onclusions. Intima-media thickness of the BA, but not
MD, predicted long-term (up to four years) cardiovascular
vents in a population with chest pain with or without
nderlying CAD. Whether morphologic examination of
ifferent vascular beds in combination with serial measure-
ents of FMD may improve the identification of high-risk
atients remains to be established.
eprint requests and correspondence: Dr. Franz Weidinger,
ivision of Cardiology, Innsbruck Medical University, Anich-
trasse 35, A-6020 Innsbruck, Austria. E-mail: F.Weidinger@
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